Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_34ed32e07fc9c088d433c4abc57b61a3 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-138 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-138 |
filingDate |
2018-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2020-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a988b50e748003b5f4648265cff8b70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83db691378e0d596271eec91fc32fc24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_251721b0862d83be6d7e8241654515ea |
publicationDate |
2020-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-10828270-B2 |
titleOfInvention |
Oxprenolol compositions for treating cancer |
abstract |
The present invention relates to compositions of S-enantiomer enriched oxprenolol and their use in treating cancer and treating or preventing, in cancer patients, cachexia, body weight loss, lean body mass loss and adipose tissue loss, and improving quality of life and prolonging survival of cancer patients. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11433036-B2 |
priorityDate |
2013-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |